Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Ocera Therapeutics Inc (NASDAQ:OCRX)

3.85
Delayed Data
As of Sep 03
 -0.01 / -0.26%
Today’s Change
3.30
Today|||52-Week Range
8.10
-39.56%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues10.2M8.4M85.0K341.0K
 
 
 
 
 
Depreciation And Amortization308.0K332.0K324.0K200.0K
 
 
 
 
 
 
Operating ExpensesGross Income-----239.0K141.0K
 
 
 
General Expenses30.6M27.2M12.0M24.8M
 
 
 
 
 
Research And Development24.9M21.0M3.5M14.9M
 
 
 
 
 
Total Operating Expenses30.9M27.5M12.3M25.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-20.7M-19.1M-12.3M-24.7M
 
 
 
 
 
Extraordinary Credit0.000.0015.0K--
 
 
Extraordinary Charge0.00-1.4M-3.1M--
 
 
 
Interest Expense On Debt1.6M2.4M193.0K12.0K
 
 
 
 
 
Other Expenses126.0K27.0K0.000.00
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-22.2M-22.8M-15.5M-24.6M
 
 
 
 
 
Discontinued Operations0.000.00-1.9M50.0K
 
 
 
Extraordinary Items0.000.00-86.0K1.1M
 
 
 
Net Income-22.2M-22.8M-17.4M-24.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS1.5M2.1M6.1M17.5M
 
 
 
 
 
Shares To Calculate EPS Diluted1.5M2.1M6.1M17.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$14.64-$10.80-$2.85-$1.34
 
 
 
 
 
EPS Diluted-$14.64-$10.80-$2.84-$1.40